FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145543667> ?p ?o ?g. }

• W2145543667 endingPage "611" @default.
• W2145543667 startingPage "606" @default.
• W2145543667 abstract "Purpose: The purpose of this study was to evaluate the incidence of thrombotic complications in patients with deep vein thrombosis (DVT) who were treated with percutaneous inferior vena caval interruption in place of anticoagulation.Methods: A retrospective review of all percutaneously placed inferior vena cava filters for 1 year, August 1993 through July 1994, was performed.Results: Thirty-three percutaneous inferior vena cava filters were placed in 32 patients. The underlying disease was pulmonary embolism in 15 (47%) and DVT in 17 (53%) patients. Of patients with pulmonary embolism, 11 had a documented DVT, and four were not evaluated for DVT. There were 14 men and 18 women, with a mean age of 63.5 years (range 24 to 93 years). Indications for vena caval interruption were recurrent pulmonary embolism with therapeutic anticoagulation (n = 2 [6%]), prophylactic insertion with documented pulmonary embolism and therapeutic anticoagulation (n = 8 [25%]), documented pulmonary embolism and absolute contraindication to anticoagulation (n = 5 [16%]), documented DVT and absolute contraindication to anticoagulation (n = 2 [6%]), prophylactic insertion with documented DVT and therapeutic anticoagulation (n = 5 [16%]), and documented DVT with relative contraindication to anticoagulation (n = 10 [31%]). Of the 32 patients with inferior vena cava filters, 17 were not given anticoagulants (7 absolute contraindications, 10 relative contraindications), and 15 were given anticoagulants. Insertion of a percutaneous inferior vena cava filter in patients who were not given anticoagulants was followed by the development of phlegmasia cerulea dolens in four patients (24%), which was bilateral in two patients; one patient eventually died. No patients treated with inferior vena cava filter and anticoagulation had development of phlegmasia.Conclusions: Percutaneous inferior vena caval interruption effectively prevents pulmonary embolism in patients with DVT but does not impact the underlying thrombotic process and in fact may contribute to progressive thrombosis in patients who are not given anticoagulants. Anticoagulation with intravenous heparin is safe and effective therapy for DVT in most patients. We believe that percutaneous insertion of vena cava filters should not replace anticoagulation in routine proximal DVT, and those patients who require an inferior vena cava filter for failure of anticoagulation should continue to receive heparin to treat the primary thrombotic process. We caution that relative contraindications to anticoagulation should be carefully scrutinized before recommending vena cava interruption as a primary therapy for DVT. (J VASC SURG 1995;22:606-11.)" @default.
• W2145543667 created "2016-06-24" @default.
• W2145543667 creator A5003894791 @default.
• W2145543667 creator A5008116594 @default.
• W2145543667 creator A5024571142 @default.
• W2145543667 creator A5041175129 @default.
• W2145543667 date "1995-11-01" @default.
• W2145543667 modified "2023-10-18" @default.
• W2145543667 title "Phlegmasia complicating prophylactic percutaneous inferior vena caval interruption: A word of caution" @default.
• W2145543667 cites W1592091620 @default.
• W2145543667 cites W1980150722 @default.
• W2145543667 cites W2011698630 @default.
• W2145543667 cites W2012425786 @default.
• W2145543667 cites W2014728394 @default.
• W2145543667 cites W2027577794 @default.
• W2145543667 cites W2029815665 @default.
• W2145543667 cites W2035824774 @default.
• W2145543667 cites W2040696101 @default.
• W2145543667 cites W2046050473 @default.
• W2145543667 cites W2050424823 @default.
• W2145543667 cites W2065023008 @default.
• W2145543667 cites W2069668340 @default.
• W2145543667 cites W2070315891 @default.
• W2145543667 cites W2071339391 @default.
• W2145543667 cites W2072389928 @default.
• W2145543667 cites W2073325230 @default.
• W2145543667 cites W2074401370 @default.
• W2145543667 cites W2086878131 @default.
• W2145543667 cites W2115819752 @default.
• W2145543667 cites W2129176416 @default.
• W2145543667 cites W2132469330 @default.
• W2145543667 cites W2135065162 @default.
• W2145543667 cites W4237496532 @default.
• W2145543667 cites W4252165691 @default.
• W2145543667 cites W4293857995 @default.
• W2145543667 doi "https://doi.org/10.1016/s0741-5214(95)70047-1" @default.
• W2145543667 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7494363" @default.
• W2145543667 hasPublicationYear "1995" @default.
• W2145543667 type Work @default.
• W2145543667 sameAs 2145543667 @default.
• W2145543667 citedByCount "37" @default.
• W2145543667 countsByYear W21455436672012 @default.
• W2145543667 countsByYear W21455436672013 @default.
• W2145543667 countsByYear W21455436672019 @default.
• W2145543667 countsByYear W21455436672020 @default.
• W2145543667 crossrefType "journal-article" @default.
• W2145543667 hasAuthorship W2145543667A5003894791 @default.
• W2145543667 hasAuthorship W2145543667A5008116594 @default.
• W2145543667 hasAuthorship W2145543667A5024571142 @default.
• W2145543667 hasAuthorship W2145543667A5041175129 @default.
• W2145543667 hasBestOaLocation W21455436671 @default.
• W2145543667 hasConcept C141071460 @default.
• W2145543667 hasConcept C142724271 @default.
• W2145543667 hasConcept C204787440 @default.
• W2145543667 hasConcept C2776265017 @default.
• W2145543667 hasConcept C2776494729 @default.
• W2145543667 hasConcept C2778959117 @default.
• W2145543667 hasConcept C2780011451 @default.
• W2145543667 hasConcept C2780813298 @default.
• W2145543667 hasConcept C2780828045 @default.
• W2145543667 hasConcept C2780868729 @default.
• W2145543667 hasConcept C2910216633 @default.
• W2145543667 hasConcept C71924100 @default.
• W2145543667 hasConceptScore W2145543667C141071460 @default.
• W2145543667 hasConceptScore W2145543667C142724271 @default.
• W2145543667 hasConceptScore W2145543667C204787440 @default.
• W2145543667 hasConceptScore W2145543667C2776265017 @default.
• W2145543667 hasConceptScore W2145543667C2776494729 @default.
• W2145543667 hasConceptScore W2145543667C2778959117 @default.
• W2145543667 hasConceptScore W2145543667C2780011451 @default.
• W2145543667 hasConceptScore W2145543667C2780813298 @default.
• W2145543667 hasConceptScore W2145543667C2780828045 @default.
• W2145543667 hasConceptScore W2145543667C2780868729 @default.
• W2145543667 hasConceptScore W2145543667C2910216633 @default.
• W2145543667 hasConceptScore W2145543667C71924100 @default.
• W2145543667 hasIssue "5" @default.
• W2145543667 hasLocation W21455436671 @default.
• W2145543667 hasLocation W21455436672 @default.
• W2145543667 hasOpenAccess W2145543667 @default.
• W2145543667 hasPrimaryLocation W21455436671 @default.
• W2145543667 hasRelatedWork W2352976444 @default.
• W2145543667 hasRelatedWork W2383158841 @default.
• W2145543667 hasRelatedWork W2978115577 @default.
• W2145543667 hasRelatedWork W2994903107 @default.
• W2145543667 hasRelatedWork W3030496636 @default.
• W2145543667 hasRelatedWork W3031791182 @default.
• W2145543667 hasRelatedWork W3032065286 @default.
• W2145543667 hasRelatedWork W4206746206 @default.
• W2145543667 hasRelatedWork W4313544693 @default.
• W2145543667 hasRelatedWork W3029963180 @default.
• W2145543667 hasVolume "22" @default.
• W2145543667 isParatext "false" @default.
• W2145543667 isRetracted "false" @default.
• W2145543667 magId "2145543667" @default.
• W2145543667 workType "article" @default.